8-K: MariMed Stockholders Re-Elect Directors and Approve Auditors at 2025 Annual Meeting

MariMed Inc. announced that its stockholders re-elected four directors and approved the appointment of M&K CPAs PLLC as independent auditors for the 2025 fiscal year at its Annual Meeting held on June 12, 2025.

Summary

• MariMed Inc. held its 2025 Annual Meeting of Stockholders on June 12, 2025.
• Stockholders re-elected four directors to serve until the next annual meeting: Jon R. Levine, Edward Gildea, David Allen, and Eva Selhub, M.D.
• The votes for director re-election were: Jon R. Levine (107,750,940 FOR), Edward Gildea (107,262,139 FOR), David Allen (108,372,126 FOR), and Eva Selhub, M.D. (108,468,299 FOR).
• Stockholders also approved, on an advisory basis, the appointment of M&K CPAs PLLC as the Company's independent auditors for the 2025 fiscal year.
• The advisory vote for auditors resulted in 204,058,183 FOR, 10,503,878 AGAINST, and 4,556,432 ABSTAIN/WITHHELD.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive, reflecting the successful completion of routine corporate governance matters without any reported issues or unexpected outcomes. The re-election of directors and approval of auditors are standard positive indicators of continuity.

Positives

• The re-election of all four nominated directors indicates continuity and shareholder confidence in the current board's leadership.
• The approval of M&K CPAs PLLC as independent auditors ensures standard corporate governance practices are maintained for the upcoming fiscal year.

Future Outlook

The re-elected directors will serve until the Company's next annual meeting of stockholders or until their respective successors have been duly elected and qualified. M&K CPAs PLLC will serve as independent auditors for the 2025 fiscal year.

Industry Context

This filing details routine corporate governance matters for a publicly traded company, specifically the outcomes of its annual stockholder meeting. Such events are standard across all industries for maintaining corporate structure and accountability.

Corporate Governance

Stakeholder Impact

• Shareholders: The re-election of directors and approval of auditors reflect the outcomes of shareholder votes, indicating their participation in corporate governance and support for the current board and audit firm.

Next Steps

• The re-elected directors will continue to serve until the next annual meeting of stockholders.
• M&K CPAs PLLC will serve as the Company's independent auditors for the 2025 fiscal year.

Key Dates

Keywords

MariMed Inc., SEC filing, 8-K, Annual Meeting, stockholders, director re-election, independent auditors, corporate governance, proxy statement, M&K CPAs PLLC